The Hidden Costs of Mismanaged R&D Projects in Biotech and Pharma
Mismanagement of R&D projects in biotech and pharma is more common than one might think…
19/04/2021 - 7 minutes
Opinion-based articles written by experts working across different areas of the European biotechnology industry.
Mismanagement of R&D projects in biotech and pharma is more common than one might think…
Antoine Papiernik, Chairman and Managing Partner at Sofinnova Partners, looks back at where he was…
Culture influences your choices about money. This applies in normal life, but also in the…
In the current trade standoff between the US and China, Europe has a golden opportunity…
From CEO-itis to FDA-itis, the path of a biotech company is never dull. Whether the…
The key for a European biotech is to find the money where it is. And…